Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-03-16

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2016.01.021PMID 26784983
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation , Characterization , and Properties of Polylactide ( PLA )-Poly ( ethylene Glycol ) ( PEG ) Copolymers : A Potential Drug Carrier

  2017cited by this paper
• Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/neu by human dendritic cells

  2015cited by this paper
• Functionalized PEG‐b‐PAGE‐b‐PLGA triblock terpolymers as materials for nanoparticle preparation

  2015cited by this paper
• Improvement of nanoprecipitation technique for preparation of gelatin nanoparticles and potential macromolecular drug loading.

  2013cited by this paper
• Influence of PEG in PEG-PLGA microspheres on particle properties and protein release.

  2012cited by this paper
• Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN).

  2012cited by this paper
• Optimization of protein encapsulation in PLGA nanoparticles

  2011cited by this paper
• Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.

  2011cited by this paper
• The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011influential reference
• Polymeric nanoparticles for drug delivery.

  2010cited by this paper
• Nanoparticles made from novel starch derivatives for transdermal drug delivery.

  2010cited by this paper
• Starch nanoparticles: a review.

  2010cited by this paper
• A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.

  2010cited by this paper
• Quantifying drug release from PLGA nanoparticulates.

  2009cited by this paper
• Quantitative and qualitative evaluation of adsorption/desorption of bovine serum albumin on hydrophilic and hydrophobic surfaces.

  2009cited by this paper
• Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.

  2009cited by this paper
• Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.

  2008cited by this paper
• Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

  2007cited by this paper
• Exploiting lymphatic transport and complement activation in nanoparticle vaccines

  2007cited by this paper
• Preparation and characterization of chitosan-based nanocomposite films with antimicrobial activity.

  2006cited by this paper
• The performance of nanocarriers for transmucosal drug delivery

  2006cited by this paper
• Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies

  2006cited by this paper
• Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.

  2005cited by this paper
• Adsorption Kinetics of Proteins at the Air-Water Interface

  2005cited by this paper
• Particulate delivery systems for vaccines.

  2005cited by this paper
• Influence of Fluorescent Labelling of Polystyrene Particles on Phagocytic Uptake, Surface Hydrophobicity, and Plasma Protein Adsorption

  2004influential reference
• Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.

  2004cited by this paper
• Colloidal drug carriers: achievements and perspectives

  2003cited by this paper
• Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

  2002cited by this paper
• Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.

  2002cited by this paper
• Chitosan nanoparticles as delivery systems for doxorubicin.

  2001cited by this paper
• PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.

  2001cited by this paper
• Biodegradable polymeric nanoparticles as drug delivery devices.

  2001cited by this paper
• 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.

  2000cited by this paper
• Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles

  2000cited by this paper
• In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.

  2000cited by this paper
• In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films.

  1999cited by this paper
• Gene transfer by DNA-gelatin nanospheres.

  1999cited by this paper
• Enzymatic degradation of poly(ε-caprolactone)/poly(dl-lactide) blends in phosphate buffer solution

  1999cited by this paper
• PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

  1999cited by this paper
• Preparation and characterization of nanoparticles containing an antihypertensive agent.

  1998cited by this paper
• Polymeric nanoparticles as delivery system for influenza virus glycoproteins.

  1998cited by this paper
• Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.

  1998influential reference
• Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration

  1998cited by this paper
• Characterization of the Block Structure and Molecular Weight of Sodium Alginates

  1997cited by this paper
• Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

  1995cited by this paper
• Use of polylactic acid for the preparation of microparticulate drug delivery systems.

  1992cited by this paper
• Peroral administration of nanoparticles

  1991cited by this paper
• Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

  1984cited by this paper
• Present and future applications of biomaterials in controlled drug delivery systems.

  1981cited by this paper

• Scalable Manufacturing Method for Model Protein-Loaded PLGA Nanoparticles: Biocompatibility, Trafficking and Release Properties

  2025cites this paper
• PLGA/TPGS nanoparticles for docetaxel delivery: the pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells.

  2025cites this paper
• Sustainability in Drug and Nanoparticle Processing.

  2023cites this paper
• Modulating the Effect of β-Sitosterol Conjugated with Magnetic Nanocarriers to Inhibit EGFR and Met Receptor Cross Talk

  2023cites this paper
• Polymer Nanoparticle-Mediated Delivery of Oxidized Tumor Lysate-based Cancer Vaccines.

  2021cites this paper
• Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor

  2021cites this paper
• Use of mPEG-PLGA nanoparticles to improve bioactivity and hemocompatibility of streptokinase: In-vitro and in-vivo studies.

  2021cites this paper
• The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats

  2021cites this paper
• PEGylation enables subcutaneously administered nanoparticles to induce antigen-specific immune tolerance.

  2021cites this paper
• Magnetic nanoparticle-decorated graphene oxide-chitosan composite as an efficient nanocarrier for protein delivery

  2021cites this paper
• Enhancement of bioactivity, thermal stability and tumor retention by self-fused concatenation of green fluorescent protein

  2021cites this paper
• Optimized rapamycin-loaded PEGylated PLGA nanoparticles: Preparation, characterization and pharmacokinetics study

  2020cites this paper
• Functionalized Multifunctional Nanovaccine for Targeting Dendritic Cells and Modulation of Immune Response.

  2020cites this paper
• Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function

  2020cites this paper
• Poly(ethylene glycol) or poly(2-ethyl-2-oxazoline) – A systematic comparison of PLGA nanoparticles from the bottom up

  2020cites this paper
• Preparation, characterisation and in vitro/in vivo anticancer activity of lyophilised artesunate-loaded nanoparticles

  2020cites this paper
• Synthesis of a fructose decorated PAGE-b-PEG-b-PLGA polymer with subsequent formulation of nanoparticles

  2020cites this paper
• Rational design of PLGA nanoparticles vaccine delivery systems to improve immune responses.

  2019cites this paper
• Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical Internalization

  2019cites this paper
• Nanocarriers for Protein Delivery to the Cytosol: Assessing the Endosomal Escape of Poly(Lactide-co-Glycolide)-Poly(Ethylene Imine) Nanoparticles

  2019cites this paper
• Biodegradable Block Copolymers and Their Applications for Drug Delivery

  2019cites this paper
• Effect of segment structures on the hydrolytic degradation behaviors of totally degradable poly(L‐lactic acid)‐based copolymers

  2019cites this paper
• Preparation of maltodextrin nanoparticles and encapsulation of bovine serum albumin - influence of formulation parameters.

  2019cites this paper
• Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin

  2019influential citation
• Design and Characterization of Surface‐Crosslinked Gelatin Nanoparticles for the Delivery of Hydrophilic Macromolecular Drugs

  2019cites this paper
• Long-Acting Release Microspheres Containing Novel GLP-1 Analog as an Antidiabetic System.

  2018cites this paper
• CORAL: Predictive models for cytotoxicity of functionalized nanozeolites based on quasi-SMILES.

  2018cites this paper
• Cross-Linked Enzyme Aggregates as Versatile Tool for Enzyme Delivery: Application to Polymeric Nanoparticles.

  2018cites this paper
• Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications

  2018cites this paper
• Poly(lactic-co-glycolic acid): The most ardent and flexible candidate in biomedicine!

  2018influential citation
• Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy

  2017cites this paper
• Ciprofloxacin‐loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections

  2017cites this paper
• A tumour microenvironment-responsive polymeric complex for targeted depletion of tumour-associated macrophages (TAMs).

  2017cites this paper
• Encapsulation of the reductase component of p-hydroxyphenylacetate hydroxylase in poly(lactide-co-glycolide) nanoparticles by three different emulsification techniques.

  2017cites this paper
• GPVI‑Fc‑PEG improves cerebral infarct volume and cerebral thrombosis in mouse model with cerebral thrombosis.

  2017cites this paper
• Recombinant spider silk protein particles for a modern vaccination approach

  2017cites this paper
• Evaluation of anti-HER2 scFv-conjugated PLGA–PEG nanoparticles on 3D tumor spheroids of BT474 and HCT116 cancer cells

  2016cites this paper
• Benzoic-Imine-Based Physiological-pH-Responsive Materials for Biomedical Applications.

  2016cites this paper